Gastrointestinal Cancer: Clinical Trials

250 trials for Gastrointestinal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

100 completed, 47 recruiting, 45 unknown, 21 terminated. 95 Not applicable, 59 Phase 2, 37 Phase 1, 8 Phase 3, 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable95Completed 43, Recruiting 15, Unknown 15, Active not recruiting 6, Not yet recruiting 5, Terminated 4, Withdrawn 4, Suspended 2, Enrolling by invitation 1
Phase 259Completed 22, Recruiting 12, Terminated 10, Unknown 8, Active not recruiting 3, Not yet recruiting 2, Withdrawn 2
Phase 137Completed 14, Recruiting 12, Terminated 4, Unknown 3, Active not recruiting 2, Withdrawn 2
Phase 38Completed 3, Terminated 3, Recruiting 2
Early Phase 17Recruiting 2, Terminated 2, Unknown 2, Completed 1
Phase 44Completed 2, Recruiting 1, Unknown 1

Follow Gastrointestinal Cancer: new trials by email Literature Review of Gastrointestinal Cancer trials Research Report on Gastrointestinal Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer
Stool Sample, App Activity - Gastrointestinal, Mobile Health
Not applicableNot yet recruitingMasonic Cancer Center, University of Minnesota2002026-12-012026-06-22
MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastrointestinal Cancers
Mismatch repair (MMR) status, Lymphatic invasion status - Gastric / Gastroesophageal Junction Adenocarcinoma, Mismatch Repair Deficient or MSI-High Solid Tumors
Not yet recruitingShanghai Zhongshan Hospital50002026-11-012026-10-27
MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
MyPatientPal+ - Breast Cancer, Gastrointestinal Cancer
Not applicableNot yet recruitingBarbara Ann Karmanos Cancer Institute1002026-11-012026-11-10
A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer
TheraSphere - Gastrointestinal Cancer
Not applicableNot yet recruitingCentre Georges Francois Leclerc182026-10-012026-05-13
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Endoscopic ultrasound examination - Pancreatic Disease, Pancreatic Cancer
Not applicableRecruitingOrlando Health, Inc.1402026-10-012026-10-20
NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers
Gastrointestinal Cancer, Gastric Cancer
Not yet recruitingPeking University Cancer Hospital & Institute2002026-09-012026-08-20
Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology
Multidisciplinary Team Clinical Decision Assessment, Multimodal Artificial Intelligence-Based Clinical Decision Assessment - Gastric Cancer, Colorectal Cancer
Not yet recruitingShanghai Minimally Invasive Surgery Center692026-08-052026-08-05
Butyrate Yogurt for Cancer Constipation
butyrate-containing short-chain fatty acid yogurt - Constipation, Gastrointestinal Cancer
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital302026-08-012026-07-23
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
NOM, RO - Gastrointestinal Cancer, Colorectal (Colon or Rectal) Cancer
Not yet recruitingPeking University Cancer Hospital & Institute502026-06-152026-06-18
Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery
Digitally Supported Multimodal Prehabilitation - Gastrointestinal Neoplasms, Pancreatic Neoplasms
Not applicableNot yet recruitingLudwig Boltzmann Institute for Digital Health and Prevention302026-06-012026-06-18
Preoperative Frailty and Postoperative Outcomes in Older Patients Undergoing Surgery for Gastrointestinal Cancer
Fried Frailty Index, Clinical Frailty Scale - Gastrointestinal Cancer, Frailty
RecruitingVan Training and Research Hospital1002026-06-012026-09-15
EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers
LH BLU, ONS - Gastrointestinal Cancer
Not applicableNot yet recruitingIRCCS San Raffaele882026-06-012026-05-15
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
Dabrafenib, Trametinib - Haematological Malignancy, Malignant Neoplasm
Phase 2 / Phase 3RecruitingCancer Research UK302026-04-012026-08-17
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Breast Cancer, Lung Cancer
RecruitingUniversity Health Network, Toronto70002026-03-312026-08-21
Establishment of a Biological Collection to Develop Translational Preclinical Models for the Study of Tumors and Diseases of the Gastrointestinal Tract
biopsy - Gastrointestinal Cancer, IBD
Not applicableRecruitingUniversity Hospital, Strasbourg, France4002026-03-182026-08-24
Food-related Quality of Life in Patients With Cancer
Self-reported questionnaires, Salivary and sensory tests - Breast Cancer, Head and Neck Cancers
Not yet recruitingHospices Civils de Lyon1802026-03-012026-02-27
Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer
XH001 injection, Tumor vaccine-induced specific T-cell injection - Gastrointestinal Cancer
Phase 1RecruitingBeijing GoBroad Hospital182026-02-012026-02-12
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
DB-1324 - Gastrointestinal Cancer
Phase 1 / Phase 2RecruitingDualityBio Inc.1272026-01-202026-05-22
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
CYTALUX™ (pafolacianine) - Gastrointestinal Cancer, Gastric Cancer
Phase 4RecruitingCedars-Sinai Medical Center152025-09-052026-11-02
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
Hyperthermia, Immunotherapy - Gastrointestinal Cancer, Immunotherapy
Phase 2Not yet recruitingChina Medical University, China402025-08-152025-08-12

Showing 20 of 250. Sign in to see all of them.

Narrower conditions

Gastrointestinal Neoplasms (250)  ·  Breast Neoplasms (46)  ·  Lung Neoplasms (36)  ·  Colorectal Neoplasms (35)  ·  Neoplasms (31)  ·  Pancreatic Neoplasms (29)  ·  Stomach Neoplasms (29)  ·  Head and Neck Neoplasms (23)  ·  Esophageal Neoplasms (19)  ·  Colonic Neoplasms (18)  ·  Melanoma (17)  ·  Rectal Neoplasms (14)  ·  Liver Neoplasms (12)  ·  Ovarian Neoplasms (12)  ·  Urogenital Neoplasms (12)

Broader conditions

Neoplasms by Site (249)  ·  Digestive System Diseases (247)  ·  Gastrointestinal Diseases (245)  ·  Digestive System Neoplasms (244)  ·  Neoplasms (219)  ·  Skin Diseases (54)  ·  Skin and Connective Tissue Diseases (54)  ·  Intestinal Neoplasms (50)  ·  Pathological Conditions, Signs and Symptoms (50)  ·  Intestinal Diseases (49)  ·  Breast Diseases (48)  ·  Colonic Diseases (47)  ·  Lung Diseases (46)  ·  Respiratory Tract Diseases (46)  ·  Respiratory Tract Neoplasms (45)

Interventions

Surveys and Questionnaires (10)  ·  Oxaliplatin (8)  ·  Capecitabine (7)  ·  Blood Specimen Collection (5)  ·  Cisplatin (5)  ·  Fluorouracil (5)  ·  Cyclophosphamide (4)  ·  Leucovorin (4)  ·  aldesleukin (4)  ·  atezolizumab (4)  ·  fludarabine (4)  ·  Bevacizumab (3)  ·  Irinotecan (3)  ·  Nivolumab (3)  ·  Standard of Care (3)

Sponsors

M.D. Anderson Cancer Center (13)  ·  National Cancer Institute (NCI) (13)  ·  Dana-Farber Cancer Institute (8)  ·  Abramson Cancer Center at Penn Medicine (6)  ·  Memorial Sloan Kettering Cancer Center (5)  ·  Stanford University (4)  ·  Amgen (3)  ·  Cedars-Sinai Medical Center (3)  ·  H. Lee Moffitt Cancer Center and Research Institute (3)  ·  Massachusetts General Hospital (3)  ·  Peking University Cancer Hospital & Institute (3)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3)  ·  Société des Produits Nestlé (SPN) (3)  ·  Wake Forest University Health Sciences (3)  ·  Baylor College of Medicine (2)

Countries

United States (118)  ·  China (36)  ·  Canada (8)  ·  Italy (8)  ·  France (7)  ·  United Kingdom (7)  ·  Turkey (Türkiye) (6)  ·  Australia (4)  ·  Germany (4)  ·  Hong Kong (4)  ·  Netherlands (4)  ·  Singapore (4)  ·  South Korea (4)  ·  Switzerland (4)  ·  Taiwan (4)

Top investigators

Steven A Rosenberg, M.D. (6)  ·  James C Yang, M.D. (2)  ·  Lillian Siu, MD (2)  ·  Sony Tuteja, PharmD, MS (2)  ·  Tim F Greten, M.D. (2)  ·  Wei Peng Yong (2)  ·  Ziyu Li, MD PhD (2)  ·  Abdul Naqash, MD (1)  ·  Ahmed Elsayem, MD,MPH (1)  ·  Alessandro Passardi, MD (1)  ·  Alex Chang (1)  ·  Alexey Tryakin, MD, PhD, professor (1)

Results publications

PMID 11222424, PMID 18279948, PMID 19164203, PMID 20717178, PMID 20838998, PMID 21468643, PMID 22011937, PMID 22673593, PMID 22810696, PMID 23361051, PMID 23439759, PMID 23580238, PMID 23708720, PMID 24379639, PMID 24512954, PMID 25228170, PMID 25250176, PMID 25591799, PMID 25801106, PMID 26049686, PMID 26290648, PMID 26441396, PMID 27520560, PMID 28572459, PMID 28643069, PMID 28741175, PMID 28753429, PMID 28969327, PMID 29149865, PMID 29259073, PMID 29305245, PMID 29442240, PMID 29846827, PMID 30041978, PMID 30139941, PMID 30221011, PMID 30381282, PMID 31060836, PMID 31452053, PMID 31463699, PMID 31486730, PMID 31586566, PMID 31647691, PMID 32088854, PMID 32380558, PMID 32675754, PMID 32729929, PMID 32737706, PMID 32819443, PMID 33016924

NIH funding

1UM1CA233080-01 (1), 2014 (1), 2018 (1), 2019 (1), 2025 (1), F32CA278417 (1), K08CA230185 (1), K22CA262352 (1), N01CM17104 (1), P30CA012197 (1), P30CA022453 (1), R01CA270040 (1), R01HG012273 (1), R21CA223684 (1), R21NR021083 (1)